No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Codexis to Sell Pompe, Fabry Assets to Crosswalk Therapeutics
6-K: Report of foreign private issuer (related to financial reporting)
20-F: Registration statement / Annual report / Transition report
6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders
Takeda Announces the Publication of Its Annual Report on Form 20-F for FY2023
Wave Jumps on Trial Data for Huntington's Disease Therapy